Shenzhen Noposion Crop Science Future Growth
Future criteria checks 3/6
Shenzhen Noposion Crop Science is forecast to grow earnings and revenue by 32.4% and 5.7% per annum respectively. EPS is expected to grow by 31.8% per annum. Return on equity is forecast to be 18.7% in 3 years.
Key information
32.4%
Earnings growth rate
31.8%
EPS growth rate
| Chemicals earnings growth | 39.3% |
| Revenue growth rate | 5.7% |
| Future return on equity | 18.7% |
| Analyst coverage | Low |
| Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
A Piece Of The Puzzle Missing From Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) 26% Share Price Climb
Dec 12
Shenzhen Noposion Crop Science (SZSE:002215) Takes On Some Risk With Its Use Of Debt
Nov 25We Ran A Stock Scan For Earnings Growth And Shenzhen Noposion Crop Science (SZSE:002215) Passed With Ease
Oct 26Even With A 26% Surge, Cautious Investors Are Not Rewarding Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Performance Completely
Sep 24These 4 Measures Indicate That Shenzhen Noposion Crop Science (SZSE:002215) Is Using Debt Extensively
Aug 20With EPS Growth And More, Shenzhen Noposion Crop Science (SZSE:002215) Makes An Interesting Case
Jul 19Estimating The Intrinsic Value Of Shenzhen Noposion Crop Science Co., Ltd. (SZSE:002215)
Apr 02Investors Still Aren't Entirely Convinced By Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Earnings Despite 26% Price Jump
Mar 04Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5,452 | 1,029 | N/A | 1,432 | 3 |
| 12/31/2025 | 5,121 | 861 | N/A | 1,117 | 3 |
| 12/31/2024 | 4,643 | 641 | N/A | 682 | 3 |
| 9/30/2024 | 4,955 | 443 | 63 | 1,157 | N/A |
| 6/30/2024 | 4,973 | 450 | 314 | 1,304 | N/A |
| 3/31/2024 | 4,601 | 472 | 377 | 1,329 | N/A |
| 12/31/2023 | 4,120 | 236 | -345 | 640 | N/A |
| 9/30/2023 | 4,119 | 307 | -524 | 474 | N/A |
| 6/30/2023 | 4,187 | 345 | -360 | 695 | N/A |
| 3/31/2023 | 4,337 | 381 | -438 | 517 | N/A |
| 1/1/2023 | 4,265 | 328 | -730 | 175 | N/A |
| 9/30/2022 | 4,404 | 276 | -490 | 394 | N/A |
| 6/30/2022 | 4,522 | 323 | -588 | 127 | N/A |
| 3/31/2022 | 4,556 | 323 | -576 | 54 | N/A |
| 1/1/2022 | 4,501 | 305 | -85 | 422 | N/A |
| 9/30/2021 | 4,112 | 212 | -199 | 178 | N/A |
| 6/30/2021 | 4,203 | 197 | 3 | 322 | N/A |
| 3/31/2021 | 4,167 | 184 | 193 | 475 | N/A |
| 12/31/2020 | 4,131 | 167 | 286 | 539 | N/A |
| 9/30/2020 | 4,164 | 259 | -125 | 85 | N/A |
| 6/30/2020 | 4,138 | 240 | -227 | 21 | N/A |
| 3/31/2020 | 4,141 | 229 | -183 | 123 | N/A |
| 12/31/2019 | 4,058 | 236 | -116 | 178 | N/A |
| 9/30/2019 | 4,098 | 296 | 354 | 621 | N/A |
| 6/30/2019 | 4,108 | 313 | 316 | 509 | N/A |
| 3/31/2019 | 4,070 | 306 | 194 | 302 | N/A |
| 12/31/2018 | 4,005 | 329 | -29 | 80 | N/A |
| 9/30/2018 | 3,758 | 354 | -374 | -275 | N/A |
| 6/30/2018 | 3,511 | 359 | N/A | -502 | N/A |
| 3/31/2018 | 2,997 | 355 | N/A | -646 | N/A |
| 12/31/2017 | 2,822 | 309 | N/A | -441 | N/A |
| 9/30/2017 | 2,497 | 214 | N/A | -835 | N/A |
| 6/30/2017 | 2,214 | -28 | N/A | -657 | N/A |
| 3/31/2017 | 2,166 | -239 | N/A | -341 | N/A |
| 12/31/2016 | 1,963 | -276 | N/A | -378 | N/A |
| 9/30/2016 | 2,125 | -206 | N/A | 195 | N/A |
| 6/30/2016 | 2,171 | -8 | N/A | 636 | N/A |
| 3/31/2016 | 2,166 | 225 | N/A | 755 | N/A |
| 12/31/2015 | 2,210 | 231 | N/A | 853 | N/A |
| 9/30/2015 | 2,028 | 213 | N/A | 554 | N/A |
| 6/30/2015 | 2,123 | 215 | N/A | 239 | N/A |
| 3/31/2015 | 2,258 | 210 | N/A | 378 | N/A |
| 12/31/2014 | 2,203 | 194 | N/A | 306 | N/A |
| 9/30/2014 | 2,124 | 188 | N/A | 239 | N/A |
| 6/30/2014 | 2,045 | 240 | N/A | 245 | N/A |
| 3/31/2014 | 1,876 | 200 | N/A | 163 | N/A |
| 12/31/2013 | 1,736 | 180 | N/A | 207 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002215's forecast earnings growth (32.4% per year) is above the savings rate (2.8%).
Earnings vs Market: 002215's earnings (32.4% per year) are forecast to grow faster than the CN market (25.7% per year).
High Growth Earnings: 002215's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 002215's revenue (5.7% per year) is forecast to grow slower than the CN market (13.7% per year).
High Growth Revenue: 002215's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002215's Return on Equity is forecast to be low in 3 years time (18.7%).